Vital 3M Shareholder Criticizes CEO Mike Roman's Leadership; Urges Overhaul

• Bert Flossbach, a significant shareholder of 3M Co (NYSE: MMM), flagged concerns about CEO Mike Roman’s leadership, even suggesting a management overhaul.

• Bert Flossbach, the co-founder and senior portfolio manager of German mutual-fund firm Flossbach von Storch AG, said 3 M’s revenue and earnings have disappointed since Roman became CEO in 2018, the Wall Street Journal reports. 3 M’s shareholder loss of 32% stacked against a 62% gain in the S&P 500.

• 3M battled litigation over military earplugs and the “forever chemicals” known as PFAS, and its share price has dropped about 28% over the past 12 months.

• Flossbach said he was primarily concerned with 3M’s operations versus the litigation.

• In January, 3M reported a quarterly profit of $541 million, or 98 cents a share, compared with $1.34 billion, or $2.31 a share, a year earlier.

• The company projected that its sales in 2023 would fall by 6% - 2% and forecasted adjusted EPS of $8.50 - $9.00.

• 3M disclosed plans to cut 2,500 manufacturing jobs globally.

• Roman said the company focused “on delivering for customers and shareholders in a challenging economic environment with slowing growth, inflation, and supply chain disruptions.”

• 3M said China’s Covid-19 resurgence and 3M’s exit from its business in Russia last year hurt the financial performance. Demand for the company’s disposable face masks is returning to pre-pandemic levels, 3M has said.

• Flossbach’s letter said the company appears to be handling the PFAS issues well and that the military earplug complaints seem unjustified.

• Price Action: MMM shares are trading lower by 0.49% at $119.70 in the premarket on the last check Friday.

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

This article Vital 3M Shareholder Criticizes CEO Mike Roman's Leadership; Urges Overhaul originally appeared on Benzinga.com

.

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.